India-US trade deal: Commerce Ministry shares update on Piyush Goyal’s visit; says aim to ‘achieve early conclusion’

A delegation headed by Piyush Goyal conducted an official visit to the US from September 22-24, 2025. (AI image) India-US trade deal talks: India and the US have decided to continue working towards an early conclusion to the trade agreement, according to a statement by the Ministry of Commerce & Industry.Sharing an update on Commerce…

Read More

Boost for IAF! HAL looks to secure billion-dollar GE engine deal for LCA Tejas Mk1A; India-US defence ties in focus

India is on track to finalise a $1 billion deal with US aerospace firm General Electric (GE) for 113 F404-IN20 fighter jet engines, as negotiations between the two countries continue.The engines will power India’s indigenous LCA Tejas Mk1A, supporting the government’s Atmanirbhar Bharat defence initiative. Tejas Mk1A Defence Deal Hailed by HAL CMD as Boost…

Read More

Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in

For Indian pharmaceutical exports, the US represents the primary market, comprising approximately 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…

Read More

Unclaimed money in mutual funds shot up 20% in 2024-25: Over Rs 3,400 crore of unclaimed dividend, redemptions lying with MFs, says SEBI

This growing pile of unclaimed wealth reflects not just investor negligence but also structural issues that need attention. Unclaimed money in mutual funds has touched worrying levels. According to the Sebi annual report, dividends and redemption proceeds lying unclaimed with mutual fund houses shot up to Rs 3,452 crore in 2024-25, up 20% from Rs…

Read More

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…

Read More